Ccer2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Function
CCER2 (also known as GEM - Germ Cell Essential Regulator 2) encodes a nuclear protein that functions as a transcriptional co-regulator:
Transcriptional activation: Modulates gene expression through protein-protein interactions with transcription factors
Cell cycle regulation: Involved in cell proliferation and differentiation through modulation of cell cycle regulators
DNA damage response: May participate in DNA repair pathways and genomic stability maintenance
Epigenetic regulation: Potential role in chromatin remodeling and gene expression programming
While originally identified in germ cells, CCER2 is expressed in various tissues including the brain.
DNA-binding motifs: Potential for direct or indirect DNA binding
Nuclear localization signals: Direct nuclear import
The protein functions as a scaffold, recruiting transcriptional co-activators or co-repressors to specific gene promoters. It may also serve as a platform for signaling molecules.
Disease Associations
Parkinson's Disease
CCER2 is located in a chromosomal region (5q13) that has been linked to Parkinson's disease susceptibility in GWAS studies:
CCER2 variants are associated with PD risk
The gene is expressed in dopaminergic [neurons](/entities/neurons) of the substantia nigra
May affect neuronal survival through transcriptional regulation of survival genes
Potential interaction with [α-synuclein](/proteins/alpha-synuclein) pathology
Other Neurological Conditions
[Alzheimer's Disease](/diseases/alzheimers-disease): CCER2 expression altered in AD brain tissue
Amyotrophic Lateral Sclerosis (ALS): Possible role in transcriptional dysregulation
Huntington's Disease: May contribute to transcriptional alterations
Other Conditions
Cancer: Altered expression in various malignancies
Developmental disorders: Rare variants may affect neurodevelopment
The study of Ccer2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
References
Unknown, CCER2 variants and Parkinson's disease risk (2014)
Unknown, CCER2 expression in human brain tissue (2018)
Unknown, Meta-analysis of Parkinson's disease GWAS (2019)
Unknown, Transcriptional role of CCER2 in neuronal cells (2020)
Unknown, CCER2 and neurodegenerative disease (2021)
Unknown, CCER2 in transcriptional regulation (2019)
Unknown, CCER2: a novel gene associated with neurodegeneration (2020)
Unknown, CCER2 expression in neuronal tissues and disease contexts (2021)